Articles

Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways

Department of Pathology, The Ohio State University, Columbus, OH, USA
Department I for Internal Medicine and Center of Integrated Oncology, University of Cologne, Germany
Department of Experimental Therapeutics, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
Department of Internal Medicine, The Ohio State University, Columbus, OH, USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
Department of Biomedical Informatics, The Ohio State University, Columbus, OH, USA
Vol. 103 No. 12 (2018): December, 2018 https://doi.org/10.3324/haematol.2018.190132